PatientProfiler: A network-based approach to personalized medicine
Lombardi, V.; Di Rocco, L.; Meo, E.; Venafra, V.; Di Nisio, E.; Perticaroli, V.; Nicolaeasa, M. L.; Cencioni, C.; Spallotta, F.; Negri, R.; Sacco, F.; Perfetto, L.
Show abstract
Deciphering the intricate mechanisms underlying reprogramming in cancer cells is a crucial challenge in oncology as it holds the key to advance our ability to diagnose and treat cancer patients. For this reason, comprehensive and patient-specific multi-omic characterization of tumor specimens has become increasingly common in clinical practice. While these efforts have advanced our understanding of the molecular mechanisms underlying breast cancer progression, the identification of personalized therapeutic approaches remains a distant goal. The main shortcoming is the absence of a robust computational framework to integrate and interpret the available multi-dimensional data and to drive translational solutions. To fill this gap, we developed PatientProfiler, a computational pipeline that leverages causal interaction data, annotated in our in-house manually-curated resource, SIGNOR, to address how the genetic and molecular background of single patients contributes to the establishment of a malignant phenotype. PatientProfiler is an open-source, R-based package composed of several functions that allows multi-omic data analysis and standardization, generation of patient-specific mechanistic models of signal transduction, and extraction of network-based prognostic biomarkers. To benchmark the tool, we retrieved genomic, transcriptomic, (phospho)proteomic, and clinical data derived from 122 treatment-naive breast cancer biopsies, available at the CPTAC portal. Thanks to this approach, we identified patient-specific mechanistic models (one patient, one network) that recapitulate dysregulated signaling pathways in breast cancer. This collection of models provides valuable insights into the underlying mechanisms of tumorigenesis and disease progression. Moreover, in-depth topological exploration of these networks has allowed us to define seven communities (subnetworks), each associated with a unique transcriptomic signature and a distinct prognostic value. In summary, our work demonstrates that PatientProfiler is a tool for patient-specific network analysis, advancing personalized medicine towards the identification of actionable biomarkers and tailored therapeutic strategies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluation of single-sample network inference methods for precision oncology 95%
- Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients' blood 94%
- Spatial cell graph analysis reveals skin tissue organization characteristic for cutaneous T cell lymphoma 94%
Similar papers in this journal
- stLearn: integrating spatial location, tissue morphology and gene expression to find cell types, cell-cell interactions and spatial trajectories within undissociated tissues 96%
- Spatially Interacting Phosphorylation Sites and Mutations in Cancer 95%
- Identification of Relevant Genetic Alterations in Cancer using Topological Data Analysis 95%
Similar papers in this journal
- OnCorr: A pan-cancer mRNA-protein correlation tool for precision oncology 94%
- Generalizing AI-driven Assessment of Immunohistochemistry across Immunostains and Cancer Types: A Universal Immunohistochemistry Analyzer 94%
- Development and validation of a gene expression score to account for tumour purity and improve prognostication in breast cancer 94%
Similar papers in this journal
- Network-based approach elucidates critical genes in BRCA subtypes and chemotherapy response in Triple Negative Breast Cancer 96%
- Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancer 94%
- Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients. 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.